Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biologica...
OrigiMed has announced that the Human NTRK1/2/3 Genomic Alteration Testing Kit has been granted the Special Review ...
With the ongoing worldwide COVID-19 pandemic, an increasing number of viral variants are being identified, which poses a...
China’s overall focus within oncology research is increasing at a rapid pace. Moreover, the country recently appro...
Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...
An international research team led by scientists from the Hong Kong University of Science and Technology (HKUST) has dev...
China National Medical Products Administration (NMPA) has approved GC Pharma's GreenGene F (Beroctocog alfa) [Recom...
Hong Kong-based PHASE Scientific International has announced that its INDICAID™ COVID-19 Rapid Antigen Test (...
Hong Kong-based New World Development (NWD) and Prenetics have jointly announced the launch of the Circle HealthPod...
A collaborative study between scientists at the Shanghai University of Traditional Chinese Medicine and AntiCancer Inc. ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
Shanghai Promega Biological Products and Shanghai Henlius Biotech, Inc. will develop and commercialize a microsatellite ...
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) reports a ground breaking discove...
Micomme has associated with Polish and Peruvian partners to accomplish the government centralized purchase of 1,600...
WuXi STA – a subsidiary of WuXi AppTec – has completed the acquisition of a drug product manufacturing facil...
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...
Eisai Co., Ltd. has developed an anti-epileptic drug (AED) Fycompa (generic name: perampanel) which obtained t...
Exyte has successfully completed the construction of the first ExyCell® facility in China, the CliniMACS C...
